Before the introduction of the Haemophilus influenzae serotype b (Hib) conjugate vaccine, Hib was a common cause of childhood meningitis and other invasive infections such as septicaemia and epiglotittis (6) . Since the introduction of the Hib conjugate vaccine in North America and Europe, disease due to Hib has become rare (9, 1) . Recent studies suggest that non-type b H. influenzae, particularly nontypeable (NT) strains, are now responsible for most of the H. influenzae disease (2, 10) . Currently, there is no vaccine available for non-type b H. influenzae and antibiotic treatment is the only effective method to combat disease caused by these strains. Antibiotic resistance in H.
influenzae was first documented in 1972 with the discovery of an ampicillin resistant isolate (4). Since then, H. influenzae has developed resistance to several other antibiotics and resistance rates continue to change over time. Therefore, it is important to monitor for antibiotic susceptibility in H. influenzae. Here we report the antibiotic susceptibility Isolates were serotyped by slide agglutination using commercial antisera (Difco, Oakville, Ontario, Canada; Denka Seiken, Tokyo, Japan) and confirmed by PCR detection of serotype-specific capsular polysaccharide synthesis genes using a previously described method (3).
β-lactamase production was detected using Dryslide nitrocefin (BBL, Becton Dickinson, Oakville, Ontario, Canada). Disk diffusion was carried out as described by the Clinical Laboratory Standards Institute (CLSI) (8) . strains were rarely found in these earlier studies (5, 11). However, in this study we found two β-lactamase positive isolates were also resistant to amoxicillin-clavulanate We thank the directors and staff of the provincial public health laboratories, St.
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